Historically, treatments for autoimmune diseases such as type 1 diabetes, myasthenia gravis, and primary biliary cholangitis have relied upon immune suppression. That approach can be effective, but suppressing a sizeable part of the immune system can leave patients vulnerable to infections and side effects such as weight gain and fatigue.
Traditional antigen-specific immune tolerance (ASIT) strategies are not fully specific and do not…